BD news and events in 2026
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help...
Get BD's live signals in Claude or ChatGPT, or by API
What changed at BD this week? Use Autobound signals for bd.com.- Dated updates
- 114
- Last event
- Oct 29, 2026
- Open rolesSnapshot Nov 3, 2026
- 394
- Latest SEC filing
- Aug 6, 2026
Source: Autobound Signal API · 114 signals tracked for BD · updated
Overview
BD by topic
108-K filings
394open roles
70+signals
46 in the last 90 days
- X (Twitter)15+
- Website changes15+
- Glassdoor13
- Patents13
- and 4 more sources
Latest events
Latest BD events
Showing 10 of 31 events. The Signal API returns all of them.
Get them with one API call- LaunchBD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment OptionsBD announced the U.S. commercial launch of the BD Liverty TIPS Stent Graft for portal hypertension care.
- In developmentBD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial ResultsBD announced positive nine-month clinical trial results from the AGILITY IDE study evaluating its investigational Revello Vascular Covered Stent.
- PromotionBD Appoints Ferass Abuzaina as Worldwide President of SurgeryFerass Abuzaina, worldwide president of the Surgery business unit
- InvestmentBD partners with U.S. government to invest $19B in domestic medical supply manufacturing.BD announced plans to invest $19 billion to expand domestic manufacturing of essential medical consumables across multiple U.S. locations.
- PartnershipBD Partners with US Government on $19B manufacturing expansionWith U.S. government
- Executive hireArthur Hu to Join BD as Chief Information and Digital OfficerArthur Hu, executive vice president and chief information and digital officer
- New customerBD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at FairviewWith Fairview Health Services
- In developmentBD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical InnovationBD announced its STANCE clinical trial evaluating the GalaFLEX LITE™ Scaffold in breast revision surgery has reached its first enrollment milestone, with 274 patients treated, placing enrollment beyond 50% of the trial's maximum planned enrollment.
- Executive hireBD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to RetireGary Sorsher, executive vice president and chief quality officer
- In developmentBD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT TrialBD has completed enrollment for its PREVENT clinical trial, a large-scale randomized study evaluating its Phasix™ Mesh for the prevention of incisional hernias following abdominal surgery.
Showing 10 of 31 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track BD with the Signal API
One POST /v1/companies/enrich call with bd.com returns every signal type for BD, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bd.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to BD
BD questions
What is the latest news on BD?
What is going on with BD?
What else does Autobound track for BD?
Is BD hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .